Nigale was co-founded by Sichuan Academy of Medical Sciences and its affiliated hospital in 1994. In January 2025, Nigale officially joined China Resources Pharmaceutical Group Limited, becoming an important part to expand and strengthen the Group's presence in the blood collection, transfusion, and blood products sectors..

Nigale specializes in the R&D, manufacture, and sale of blood-collection and transfusion equipment, disposables, and pharmaceuticals. Holding 11 Class III medical-device registration certificates and drug approvals covering six product types and 22 specifications, it is a leading enterprise in China’s blood-collection and transfusion sector, recognized for its large-scale production, advanced technical capabilities, and the industry’s most comprehensive portfolio of market-access licenses..

Nigale is a high-tech enterprise that integrates “intelligent blood-collection and transfusion equipment and instruments with information integration and smart-interaction technology.” It was among the first group of SRUI (Specialized, Refined, Unique, Innovative) ‘Giant’ SMEs recognized in Sichuan Province and was listed in the second national batch announced by the Ministry of Industry and Information Technology (MIIT). As one of the earliest SRUI Giant SMEs to receive state support for high-quality development, Nigale also serves as a benchmark for industrial excellence in Sichuan Province..

Nigale operates several key R&D platforms: Sichuan Provincial Engineering Research Center, Sichuan Provincial Enterprise Technology Center, Chengdu Engineering Research Technology Center, Chengdu Academician (Expert) Innovation Workstation, Chengdu Future Urban Scenario Laboratory. Multiple Nigale products have been designated as National Key New Products or included in National Torch Plans and National Innovation Projects. As of the end of 2025, Nigale has participated in drafting 13 national and industry standards, with 3 of its enterprise standards upgraded to national and industry standards. The company has obtained a total of 352 intellectual property certificates, including 93 invention patents.

Globally, Nigale was the first to develop the Intelligent Plasma Separator for smart plasma-center construction. In China, the company leads the market with the Blood Component Separator, Disposable Blood Cell Apheresis Set, Room-Temperature Platelet Storage Bag, Top-and-Bottom Leukocyte-Reduced Blood Collection and Transfusion Set, Intelligent Blood Cell Processor, and a Plasma Separator featuring electronic identity recognition. Nigale products are distributed throughout China and exported to more than 50 countries in Europe, Asia, Africa, and Latin America.

With the mission of “Ensuring blood safety and safeguarding human health”, Nigale upholds the core values of “integrity and win-win cooperation”, follows the guiding principle of “actively responding to customer needs, intensifying innovation in blood-related technologies and elevating product quality standards”. It is committed to becoming a world-class enterprise specialized in blood technology.